SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-051792
Filing Date
2022-08-29
Accepted
2022-08-29 16:01:30
Documents
13
Period of Report
2022-08-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea165078-8k_biomxinc.htm   iXBRL 8-K 62997
  Complete submission text file 0001213900-22-051792.txt   292487

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20220829.xsd EX-101.SCH 4472
3 XBRL DEFINITION FILE phge-20220829_def.xml EX-101.DEF 27449
4 XBRL LABEL FILE phge-20220829_lab.xml EX-101.LAB 38219
5 XBRL PRESENTATION FILE phge-20220829_pre.xml EX-101.PRE 26069
7 EXTRACTED XBRL INSTANCE DOCUMENT ea165078-8k_biomxinc_htm.xml XML 7324
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 221211248
SIC: 2836 Biological Products, (No Diagnostic Substances)